Sponsor Pipeline

Shandong Qilu Cell Therapy Engineering Technology Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
Active Trials by Phase
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Early Phase 1
NCT07048353 CD30 CAR-T in the Treatment of CD30 Positive Lymphoma Lymphoma Not Yet Recruiting
Get alerts when Shandong Qilu Cell Therapy Engineering Technology Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free